Lawyers Seek to Restore Investors' Losses and Confidence in Affymax, Announces Deans & Lyons Law Firm LLP

  Lawyers Seek to Restore Investors' Losses and Confidence in Affymax,
  Announces Deans & Lyons Law Firm LLP

Business Wire

DALLAS -- March 11, 2013

Deans & Lyons LLP securities lawyers announced potential claims on behalf of
shareholders of Affymax (NASDAQ: AFFY) who purchased or acquired stock from
December 8, 2011 until February 22, 2013. Concerned AFFY investors with stock
losses are encouraged to contact attorney Hamilton Lindley at 877-819-8033 or
hlindley@deanslyons.com about their rights and remedies.

“Following a report that the FDA was requiring a recall of the company’s lead
drug, due to reports of ‘serious and life-threatening’ allergic reactions,
shares of Affymax declined 85%,” said shareholder rights lawyer Hamilton
Lindley. “The shareholder lawsuits, filed in the Northern District of
California, seek to compensate investors for their losses and require better
corporate governance from company management.”

Deans & Lyons has significant experience representing shareholders in
securities lawsuits nationwide. AFFY stockholders – or anyone with knowledge
about this situation – should contact lawyer Hamilton Lindley at
hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Contact:

Deans & Lyons LLP
Hamilton Lindley, 214-736-7861
Fax: 214-965-8505
Toll Free: 877-819-8033
www.deanslyons.com